To assess the efficacy of hair removing cream on healthy human subjects.

Phase 2

Completed

• Registration Number: CTRI/2017/12/010907
• Lead Sponsor: Dabur India Ltd

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2012-05-19
• Last Update Posted: 24 November 2021

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 23

Inclusion Criteria

1.Subjects in generally good health

2.Subjects in the age group of 18-35 years.

3.Subjects with moderate hair growth on lower outer forearms.

4.Subjects without any cuts, marks and open wounds on lower outer forearms.

5.Subject has not participated in a similar investigation in the past four weeks.

6.Subjects have not used a similar product for the last four weeks.

7.Subjects willing to give a written informed consent and come for regular follow up.

Exclusion Criteria

1.Subjects with known allergies or sensitivities to cosmetic products, toiletries or its components like fragrances, preservatives,hydroquinone, vitamin C, Niacin amide,retinol, soy etc.

2.Currently or has been using topical retinoids, alpha-hydroxy and/or beta-hydroxy acids,hydroquinone or any whitening/Fairness preparation in any form (cleanser, toner, cream

or soaps) within the last 1 month.

3.Currently or has been undergoing dermatologist skin treatments or procedures within the last 1 month.

4.Currently or has been involved in another skin care clinical investigation within the last 3 months.

5.Subjects who have pre-existing or dormant dermatologic conditions (e.g., psoriasis,

rosacea, rashes, eczema, many and/or severe excoriations etc.) that could interfere with

the outcome of the study as determined by the investigator.

6.Subjects with scars which could interfere with expert grader and/or instrumental

evaluations.

7.Subjects who are nursing as determined by the investigator interview during screening or

pregnant as determined by the Urine pregnancy testing after screening.

8.Subjects viewed by the investigator as not being able to complete the study.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
To evaluate the efficacy of hair removing cream and skin darkening effect on Repetitive usage on healthy human subjectsTimepoint: Day 1, Day 30 and Day 60

Secondary Outcome Measures

Name	Time	Method
safety of the subject throughout the studyTimepoint: Day 1, Day 30 and Day 60